Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
In this Q&A Report, experts discuss isolation methods, sample selection, testing techniques, and future applications of cell-free plasma samples for cancer diagnostics and treatment
Brain-Derived Tau in Blood: the Future of Alzheimer’s Disease Diagnosis?
Recently published in Brain, Gonzalez-Ortiz et al. report the design and development of a novel blood-based biomarker specific to brain-derived tau. In this blog post, we dive into the advantages of their novel immunoassay over those that are commercially available, as well as its future implications for Alzheimer’s disease diagnosis.
#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank
Anuj Kalsy and Robert Snyder showcase Precision for Medicine's variant-rich biobank, including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
The Variant-Rich Biobank: An Insider’s Look
Experts provide a showcase of Precision for Medicine's variant-rich biobank. including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
